“SAFETY CONCERNS” HALT ANOTHER COVID DRUG TRIAL
With media attention focused on the #COVID19 “vaccine unicorn”, several alternative therapeutics currently in trial are getting little attention. Monoclonal antibody cocktails,
touted by President Trump, claim to give Covid patients a boost of synthetic antibodies to help fight against the virus. Sounds great, but is there a catch? Eli Lilly has put their late-stage trial on hold due to a safety concern, leaving the public in the dark as to why.
#CovidTrials #Safety #EliLilly #OnHold #Health #Covid19 #TheHighWire
Orignal Source: https://www.bitchute.com/video/zAkwE3pQYKGr